Nurse Practitioner, Acute Care · Los Angeles, CA
NPI
1114561990
Since 2019
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8700 Beverly Boulevard
Los Angeles, CA, 90048
Phone (310) 423-2217
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$4.0M
682 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Khrister-Nikka A Berkowitz prescribed most often to Medicare patients was Orgovyx (Relugolix), with 89 prescriptions and refills. In total Khrister-Nikka A Berkowitz wrote 682 Medicare prescriptions that cost $4.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Orgovyx Relugolix | 89 | 93 | Under 11 | $239K |
| Tagrisso Osimertinib Mesylate | 75 | 76 | 12 | $1.3M |
| Dexamethasone Generic | 35 | 37 | 21 | $625 |
| Xtandi Enzalutamide | 34 | 38 | Under 11 | $505K |
| Ondansetron Hcl Generic | 34 | 34 | 21 | $712 |
| Nubeqa Darolutamide | 33 | 33 | Under 11 | $453K |
| Prednisone Generic | 32 | 56 | 16 | $299 |
| Prochlorperazine Maleate Generic | 29 | 29 | 21 | $330 |
| Abiraterone Acetate Generic | 27 | 37 | Under 11 | $75K |
| Lorbrena Lorlatinib | 24 | 24 | Under 11 | $459K |
| Bicalutamide Generic | 19 | 27 | Under 11 | $305 |
| Tabrecta Capmatinib Hydrochloride | 16 | 16 | Under 11 | $228K |
| Erlotinib Hcl Generic | 14 | 14 | Under 11 | $5,880 |
| Xalkori Crizotinib | 12 | 12 | Under 11 | $269K |
| Alecensa Alectinib Hcl | 12 | 12 | Under 11 | $130K |
Brand drugs: 334 claims; generic drugs: 348 claims; opioid claims: 13.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Khrister-Nikka A Berkowitz were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.